These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6996238)

  • 1. Lymphocytotoxic antibodies after bone marrow transplantation in aplastic anemia. II. Non-HLA antibodies.
    Gluckman E; Gluckman JC; Andersen E; Guillet J; Devergie A; Dausset J
    Transplantation; 1980 Jun; 29(6):471-5. PubMed ID: 6996238
    [No Abstract]   [Full Text] [Related]  

  • 2. Monocytotoxic antibodies after bone marrow transplantation in aplastic anemia.
    Gluckman JC; Gluckman E; Azogui O; Guillet J; Baldwin WM; Devergie A; Chapuis F; Brisson E; Andersen E; Dausset J
    Transplantation; 1982 Jun; 33(6):599-602. PubMed ID: 7048660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful engraftment of third allogeneic hematopoietic stem cell transplantation after two graft failures and treatment for anti-HLA antibody in a pediatric acquired aplastic anemia patient.
    Zhu H; Luo C; He J; Ding L; Wang J; Luo C; Chen J
    Pediatr Transplant; 2014 Dec; 18(8):896-8. PubMed ID: 25311402
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-HLA lymphocytotoxic antibodies during GVHD after bone marrow transplantation (BMT).
    Gluckman E; Andersen E; Lepage V; Dausset J
    Transplant Proc; 1977 Mar; 9(1):761-3. PubMed ID: 17200
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic mechanisms in aplastic anemia. I. Introduction: Immunological system in aplastic anemia].
    Rupniewska ZM; Dmoszyńska-Giannopoulous A
    Przegl Lek; 1982; 39(9):607-11. PubMed ID: 6758055
    [No Abstract]   [Full Text] [Related]  

  • 6. Some possible mechanisms leading to autoimmune destruction of bone marrow cells.
    Thorsby E
    Haematol Blood Transfus; 1979; 24():221-8. PubMed ID: 396176
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors leading to the appearance, after BMT, of cytotoxic antibodies against T, B and activated T lymphocytes: critical appraisal.
    Martinetti M; Conte R; Nespoli L; Capelli E; Salvaneschi L; Porta F; Prete L; Cuccia M
    Haematologica; 1990; 75(5):429-35. PubMed ID: 2097261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases.
    Gluckman E; Devergie A; Marty M; Bussel A; Rottemboúrg J; Dausset J; Bernard J
    Transplant Proc; 1978 Mar; 10(1):141-5. PubMed ID: 345552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic mechanisms in aplastic anemia.
    Finlay JL; Ershler WB; Shahidi NT
    Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of immunologic mechanisms in aplastic anemia].
    Górski A
    Acta Haematol Pol; 1978; 9(4):269-72. PubMed ID: 367032
    [No Abstract]   [Full Text] [Related]  

  • 11. The detection of non-HLA antibodies and their possible role in bone marrow graft rejection.
    Claas FH; van Rood JJ; Warren RP; Weiden PL; Su PJ; Storb R
    Transplant Proc; 1979 Mar; 11(1):423-6. PubMed ID: 377669
    [No Abstract]   [Full Text] [Related]  

  • 12. [The human bone marrow transplant. II. The transplant in aplastic anemia].
    Izzi T; Lucarelli G
    Recenti Prog Med; 1983 Feb; 74(2):199-213. PubMed ID: 6346419
    [No Abstract]   [Full Text] [Related]  

  • 13. Human marrow transplantation: an immunological perspective.
    Martin PJ; Hansen JA; Storb R; Thomas ED
    Adv Immunol; 1987; 40():379-438. PubMed ID: 2884832
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].
    Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM
    Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811
    [No Abstract]   [Full Text] [Related]  

  • 16. Marrow graft rejection and inhibition of growth in culture by serum in aplastic anaemia.
    Barrett AJ; Faille A; Saal F; Balitrand N; Gluckman E
    J Clin Pathol; 1978 Dec; 31(12):1244-8. PubMed ID: 372246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytotoxic antibodies and bone marrow grafts from HLA-identical siblings. I. HLA antibodies.
    Gluckman E; Gluckman JC; Andersen E; Devergie A; Dausset J
    Transplantation; 1978 Nov; 26(5):284-6. PubMed ID: 360532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo detection of alloreactive T cells of host origin after rejection of HLA-identical allogeneic bone marrow transplant].
    Irlé C; Kaestli M; Chapuis B; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1525-6. PubMed ID: 3909389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the response in mixed leukocyte culture of cells from patients with aplastic anemia to cells from HLA-identical siblings.
    Mickelson EM; Clift RA; Fefer A; Storb R; Thomas ED; Warren RP; Hansen JA
    Transplantation; 1981 Aug; 32(2):90-5. PubMed ID: 6457424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aplastic anemia - criteria of bone marrow transplantation].
    Reszczyński W
    Wiad Lek; 1983 May; 36(10):849-52. PubMed ID: 6353768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.